tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MIST Stock Latest News

Milestone Pharmaceuticals Reports Increased Loss Amid R&D Focus
Company AnnouncementsMilestone Pharmaceuticals Reports Increased Loss Amid R&D Focus
17d ago
MIST
Milestone Pharmaceuticals: Strong Buy Rating Backed by Anticipated Cardamyst Approval and Robust Financial Position
PremiumRatings
Milestone Pharmaceuticals: Strong Buy Rating Backed by Anticipated Cardamyst Approval and Robust Financial Position
18d ago
MIST
Milestone Pharmaceuticals Advances CARDAMYST with FDA and Financial Boost
PremiumCompany Announcements
Milestone Pharmaceuticals Advances CARDAMYST with FDA and Financial Boost
18d ago
MIST
Milestone Pharmaceuticals reports Q2 EPS (20c), consensus (18c)
PremiumThe Fly
Milestone Pharmaceuticals reports Q2 EPS (20c), consensus (18c)
18d ago
MIST
Milestone Pharmaceuticals’ Cardamyst NDA Resubmission Boosts Buy Rating Amid FDA Progress
PremiumRatings
Milestone Pharmaceuticals’ Cardamyst NDA Resubmission Boosts Buy Rating Amid FDA Progress
2M ago
MIST
Milestone Pharmaceuticals Announces Public Offering for $48.7M
PremiumCompany AnnouncementsMilestone Pharmaceuticals Announces Public Offering for $48.7M
2M ago
8K
MIST
Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?
Premium
Market News
Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?
2M ago
MIST
Milestone prices $52.5M common shares offering at $1.50 per share
Premium
The Fly
Milestone prices $52.5M common shares offering at $1.50 per share
2M ago
MIST
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
2M ago
BP
AMD
Milestone Pharmaceuticals Amends Royalty Agreement with RTW
PremiumCompany Announcements
Milestone Pharmaceuticals Amends Royalty Agreement with RTW
2M ago
8K
MIST
Milestone Pharmaceuticals commences underwritten public offering
PremiumThe Fly
Milestone Pharmaceuticals commences underwritten public offering
2M ago
MIST
Milestone announces FDA acceptance of response to CARDAMYST CRL
PremiumThe Fly
Milestone announces FDA acceptance of response to CARDAMYST CRL
2M ago
MIST
Milestone Pharmaceuticals’ Cardamyst Resubmission Boosts Buy Rating Amid Positive FDA Feedback and Market Potential
PremiumRatingsMilestone Pharmaceuticals’ Cardamyst Resubmission Boosts Buy Rating Amid Positive FDA Feedback and Market Potential
2M ago
MIST
Milestone Pharmaceuticals Submits Response to FDA for CARDAMYST
Premium
Company Announcements
Milestone Pharmaceuticals Submits Response to FDA for CARDAMYST
2M ago
8K
MIST
Milestone Pharmaceuticals sumbits CRL response for CARDAMYST nasal spray
Premium
The Fly
Milestone Pharmaceuticals sumbits CRL response for CARDAMYST nasal spray
2M ago
MIST
Milestone Pharmaceuticals Holds Annual Shareholder Meeting
PremiumCompany Announcements
Milestone Pharmaceuticals Holds Annual Shareholder Meeting
3M ago
8K
MIST
Milestone Pharmaceuticals’ Path to Approval: Addressing CMC Issues for Cardamyst’s Market Potential
PremiumRatings
Milestone Pharmaceuticals’ Path to Approval: Addressing CMC Issues for Cardamyst’s Market Potential
3M ago
MIST
Milestone Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Milestone Pharmaceuticals assumed with a Buy at H.C. Wainwright
3M ago
MIST
Milestone Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany Announcements
Milestone Pharmaceuticals Reports Q1 2025 Financial Results
4M ago
MIST
Milestone Pharmaceuticals Navigates Regulatory Challenges and Financial Updates in Q1 2025
PremiumCompany AnnouncementsMilestone Pharmaceuticals Navigates Regulatory Challenges and Financial Updates in Q1 2025
4M ago
MIST
Milestone Pharmaceuticals reports Q1 EPS (31c) vs (21c) last year
Premium
The Fly
Milestone Pharmaceuticals reports Q1 EPS (31c) vs (21c) last year
4M ago
MIST
Milestone Pharmaceuticals price target lowered to $10 from $25 at H.C. Wainwright
Premium
The Fly
Milestone Pharmaceuticals price target lowered to $10 from $25 at H.C. Wainwright
5M ago
MIST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >